Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 4Prostatic Neoplasms 3Lung Neoplasms 2Carcinoma, Renal Cell 2Weight Loss 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Sleep Apnea Syndromes 1Sezary Syndrome 1Sarcoma 1Recurrence 1Overweight 1Obesity, Morbid 1Obesity 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Hypertension 1Hyperlipidemias 1Hemangioma 1Gastroesophageal Reflux 1Eczema 1Disease 1Digestive System Diseases 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1Dermatitis, Atopic 1Collagen Diseases 1

Interventions

Oxaliplatin 32Fluorouracil 24Gemcitabine 23Leucovorin 19Docetaxel 19pembrolizumab 17Capecitabine 15Radiotherapy 14Irinotecan 13Cisplatin 11Bevacizumab 11Nivolumab 8130-nm albumin-bound paclitaxel 8Trastuzumab 7Erlotinib Hydrochloride 7Cyclophosphamide 7Albumin-Bound Paclitaxel 7Radiosurgery 6Paclitaxel 6Taxes 5S 1 (combination) 5Metformin 5Carboplatin 5Blood Specimen Collection 5Sunitinib 4Sorafenib 4Pemetrexed 4Esophagectomy 4Chemoradiotherapy 4Cetuximab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma × Urine Specimen Collection × Clear all
NCT06046131 2025-11-17

KP-CARAIBES

Centre Hospitalier Universitaire de la Guadeloupe

Phase NA Recruiting
3,000 enrolled
Genitourinary

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡